Amneal Pharmaceuticals Recalls Sulfamethoxazole Tablets Over Hazard
Amneal Pharmaceuticals recalled over 133,000 bottles of Sulfamethoxazole and Trimethoprim Tablets on August 18, 2025. The recall stems from the detection of a microorganism in the packaging material, raising health concerns. No microorganisms were found on the tablets themselves.
Product Details
The recall includes Sulfamethoxazole and Trimethoprim Tablets, USP 800mg/160mg packaged in 100-count bottles (NDC 65162-272-10) and 500-count bottles (NDC 65162-272-50). A total of 60,072 100-count and 73,054 500-count bottles are affected.
The Hazard
The recall was issued due to the presence of a microorganism detected in a specific lot of auxiliary polyester coil used in packaging. There were no reported microorganisms found on the tablets.
Reported Incidents
No injuries or illnesses related to the recall have been reported to date. The presence of a microorganism in the packaging could potentially pose health risks.
What to Do
Consumers should stop using the product immediately and contact Amneal Pharmaceuticals or their healthcare provider for further guidance. A notification letter will be sent to affected consumers.
Contact Information
For assistance, contact Amneal Pharmaceuticals, LLC at their designated customer service number or visit their website for more information.